Phage therapy program
Stanford Center for Phage Pharmaceuticals
| Status | Research/development |
|---|---|
| Type | Research |
| Location | Stanford, California; United States |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | No patient intake route verified for the newly announced center. |
|---|---|
| Areas of work | 2026 NIAID-supported translational program led by Paul Bollyky; initial focus on developing lung-delivery phages for Pseudomonas infection in CF. |
| International access | No public international-patient eligibility or acceptance policy verified. |
What to confirm
- An announced translational center and prior trial participation do not establish a current phage treatment clinic.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | stanford-phage |
|---|